-
- Vincenzo Bronte
- 1Department of Oncology and Surgical Sciences, University of Padova
-
- Tihana Kasic
- 4Venetian Institute of Molecular Medicine, 35100 Padova, Italy
-
- Giorgia Gri
- 4Venetian Institute of Molecular Medicine, 35100 Padova, Italy
-
- Keti Gallana
- 4Venetian Institute of Molecular Medicine, 35100 Padova, Italy
-
- Giovanna Borsellino
- 5Neuroimmunology Unit, Santa Lucia Foundation Scientific Institute IRCCS, 00143 Rome, Italy
-
- Ilaria Marigo
- 1Department of Oncology and Surgical Sciences, University of Padova
-
- Luca Battistini
- 5Neuroimmunology Unit, Santa Lucia Foundation Scientific Institute IRCCS, 00143 Rome, Italy
-
- Massimo Iafrate
- 2Department of Urology, University of Padova
-
- Tommaso Prayer-Galetti
- 2Department of Urology, University of Padova
-
- Francesco Pagano
- 2Department of Urology, University of Padova
-
- Antonella Viola
- 3Department of Biomedical Sciences, University of Padova
書誌事項
- 公開日
- 2005-04-11
- DOI
-
- 10.1084/jem.20042028
- 公開者
- Rockefeller University Press
この論文をさがす
説明
<jats:p>Immunotherapy may provide valid alternative therapy for patients with hormone-refractory metastatic prostate cancer. However, if the tumor environment exerts a suppressive action on antigen-specific tumor-infiltrating lymphocytes (TIL), immunotherapy will achieve little, if any, success. In this study, we analyzed the modulation of TIL responses by the tumor environment using collagen gel matrix–supported organ cultures of human prostate carcinomas. Our results indicate that human prostatic adenocarcinomas are infiltrated by terminally differentiated cytotoxic T lymphocytes that are, however, in an unresponsive status. We demonstrate the presence of high levels of nitrotyrosines in prostatic TIL, suggesting a local production of peroxynitrites. By inhibiting the activity of arginase and nitric oxide synthase, key enzymes of L-arginine metabolism that are highly expressed in malignant but not in normal prostates, reduced tyrosine nitration and restoration of TIL responsiveness to tumor were achieved. The metabolic control exerted by the tumor on TIL function was confirmed in a transgenic mouse prostate model, which exhibits similarities with human prostate cancer. These results identify a novel and dominant mechanism by which cancers induce immunosuppression in situ and suggest novel strategies for tumor immunotherapy.</jats:p>
収録刊行物
-
- The Journal of Experimental Medicine
-
The Journal of Experimental Medicine 201 (8), 1257-1268, 2005-04-11
Rockefeller University Press

